Emergent BioSolutions Inc. - Director's Dealing 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Emergent BioSolutions Inc. (EBS)
CIK: 0001367644
Period of Report: 2018-10-17

Reporting Person: Havey Adam (EVP, Business Operations)

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-10-17	Common Stock	M	314	$25.62	Acquired	29567	Direct
2018-10-17	Common Stock	S	314	$61.50	Disposed	29253	Direct

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-10-17	Stock Options (Right to Buy)	$25.62	M	314	Disposed	2021-03-10	Common Stock (314)	Direct

F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.

F2: Consists of an option granted under the company's stock incentive plan as amended and restated.

F3: The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant.